Statistics for Longboard Pharmaceuticals, (id:6754 LBPH)

Valuation metrics

Market cap

2.33B

Enterprise value

2.05B

Trailing P/E (ttm)

-25.01

Forward P/E

-21.21

PEG ratio

-21.21

Price/Sales (ttm)

Price/Book (mrq)

8.48

Enterprise Value/Revenue

Enterprise Value/EBITDA

-23.43

Overview

Shares outstanding

34.44M

Float

24.97M

Shares short

1.92M

% Held by insiders

0.01%

% Held by institutions

1.22%

Average volume (10 days)

868.98K

Average volume (90 days)

Price summary

52-Week low

3.60

52-Week high

59.95

52-Week change

93.34%

Beta

1.09

50-Day moving average

48.60

200-Day moving average

31.09

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-30.72%

Return on equity

-46.66%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-87,445,000.00

Net income to common (ttm)

-76,344,000.00

Diluted EPS (ttm)

-2.25

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

288.45M

Total cash per share (mrq)

7.39

Total debt (mrq)

3.73M

Total Debt/Equity (mrq)

1.36

Current ratio (mrq)

1.60K%

Book value per share (mrq)

7.05

Cash flow

Cash flow statement

-65,931,000.00

Levered free cash flow (LFCF)

-36,367,248.00